EDGAR Filing Documents for 0001308179-23-000757

Form DEF 14A - Other definitive proxy statements:

SEC Accession No. 0001308179-23-000757

Filing Date

2023-04-24

Accepted

2023-04-24 16:31:47

Documents

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	ULTRAGENYX PHARMACEUTICAL INC. - DEF 14A	lrare2023_def14a.htm iXBRL	DEF 14A	1239706
2	GRAPHIC	check01.jpg	GRAPHIC	1645
3	GRAPHIC	logo.jpg	GRAPHIC	14880
4	GRAPHIC	lrare2023_def14ax11x1.jpg	GRAPHIC	962
5	GRAPHIC	lrare2023_def14ax18x1.jpg	GRAPHIC	1568
6	GRAPHIC	lrare2023_def14ax26x1.jpg	GRAPHIC	1719
7	GRAPHIC	lrare2023_def14ax2x1.jpg	GRAPHIC	145843
8	GRAPHIC	lrare2023_def14ax30x1.jpg	GRAPHIC	1719
9	GRAPHIC	lrare2023_def14ax32x1.jpg	GRAPHIC	1738
10	GRAPHIC	lrare2023_def14ax40x1.jpg	GRAPHIC	14904
11	GRAPHIC	lrare2023_def14ax4x1.jpg	GRAPHIC	14145
12	GRAPHIC	lrare2023_def14ax5x1.jpg	GRAPHIC	9995
13	GRAPHIC	lrare2023_def14ax5x2.jpg	GRAPHIC	4877
14	GRAPHIC	lrare2023_def14ax5x3.jpg	GRAPHIC	5229
15	GRAPHIC	lrare2023_def14ax5x4.jpg	GRAPHIC	5663
16	GRAPHIC	lrare2023_def14ax5x5.jpg	GRAPHIC	5395
17	GRAPHIC	lrare2023_def14ax75x1.jpg	GRAPHIC	57281
18	GRAPHIC	lrare2023_def14ax75x2.jpg	GRAPHIC	63443
19	GRAPHIC	lrare2023_def14ax75x3.jpg	GRAPHIC	58565
20	GRAPHIC	lrare2023_def14ax8x1.jpg	GRAPHIC	1767
21	GRAPHIC	lrare2023_def14ax8x2.jpg	GRAPHIC	2129
22	GRAPHIC	lrare2023_def14ax8x3.jpg	GRAPHIC	1927
23	GRAPHIC	lrare2023_def14ax97x1.jpg	GRAPHIC	38038
24	GRAPHIC	lrare2023_def14ax9x1.jpg	GRAPHIC	1719
25	GRAPHIC	lrare2023_def14ax9x2.jpg	GRAPHIC	1425
26	GRAPHIC	lrare2023_def14ax9x3.jpg	GRAPHIC	62633
27	GRAPHIC	lrarex49x1.jpg	GRAPHIC	56573
28	GRAPHIC	lrarex51x1.jpg	GRAPHIC	58911
29	GRAPHIC	lrarex52x1.jpg	GRAPHIC	1778
30	GRAPHIC	lrarex52x2.jpg	GRAPHIC	1785
31	GRAPHIC	lrarex59x1.jpg	GRAPHIC	12988
32	GRAPHIC	proxy1.jpg	GRAPHIC	225626
33	GRAPHIC	proxy2.jpg	GRAPHIC	255544
34	GRAPHIC	uncheck.jpg	GRAPHIC	1060
	Complete submission text file	0001308179-23-000757.txt		4954107

Data Files

Seq	Description	Document	Type	Size
35	XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE	rare-20221231_def.xml	EX-101.DEF	5032
36	XBRL TAXONOMY EXTENSION - LABEL LINKBASE	rare-20221231_lab.xml	EX-101.LAB	18165
37	XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE	rare-20221231_pre.xml	EX-101.PRE	4018
38	XBRL TAXONOMY EXTENSION - SCHEMA	rare-20221231.xsd	EX-101.SCH	9670
41	EXTRACTED XBRL INSTANCE DOCUMENT	lrare2023_def14a_htm.xml	XML	120961

Mailing Address 60 LEVERONI COURT NOVATO CA 94949

Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800

Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)